This report was recently updated on May 12 2024 with the latest and most recent
market numbers
Global Peptides and Macrocycle Drug Discovery Platforms Market Size, Trends & Analysis - Forecasts to 2029 By Type of Platform (Peptide Synthesis, Screening Assays, Structural Biology, Computational Modeling, and Medicinal Chemistry), By Application (Oncology, Infectious Diseases, Autoimmune Disorders, Metabolic Diseases, and Neurological Conditions), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global peptides and macrocycle drug discovery platforms market is estimated to exhibit a CAGR of 10.4% from 2024 to 2029.
The primary factors propelling the market growth are the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and advancements in peptide screening technologies. Peptides and macrocycles offer unique advantages in addressing efficacy and adverse side effects challenges due to their high specificity and ability to target intricate disease mechanisms. Consequently, pharmaceutical researchers are increasingly turning to peptide drug design software and peptide library design tools to facilitate the rapid identification and optimization of peptide candidates with desired therapeutic properties. Similarly, macrocycle compound optimization techniques are being employed to enhance the macrocycle pharmacokinetics modeling and pharmacodynamic profiles of macrocycle-based drugs. This surge in demand for advanced drug discovery platforms tailored for peptides and macrocycles is fueled by the urgency to develop more effective and safer treatments for the rising burden of chronic diseases worldwide. For instance, 10.5% of adults in the world (20–79 years old) have diabetes, according to the International Diabetes Federation (IDF) Diabetes Atlas (2021) report.
Growing focus on peptide-based drug development and improvements in macrocycle library synthesis techniques are expected to support the market. Enhanced synthesis methods enable the creation of diverse and larger macrocycle libraries, expanding the scope for discovering novel drug candidates. This surge in library size amplifies the need for computational peptide modeling, and macrocycle hit identification tools to sift through vast chemical space and identify promising leads efficiently. Moreover, pharmaceutical companies increasingly rely on macrocycle drug discovery services to streamline their research processes and accelerate drug development timelines. These developments underscore the pivotal role of synthesis innovations in driving the growth of macrocycle-focused drug discovery platforms.
The availability of diverse macrocyclic compound libraries and the rising high-throughput peptide screening platform propel market growth. The high-throughput peptide screening platforms enable rapid screening of vast peptide libraries, facilitating the identification of potential drug candidates with desirable properties. As a result, researchers can expedite peptide lead optimization processes and focus resources on the most promising candidates. Furthermore, the integration of peptide-protein interaction analysis tools allows for a deeper understanding of the molecular mechanisms underlying peptide activity, aiding in selecting candidates with optimal pharmacological profiles. Additionally, high-throughput screening techniques are increasingly utilized for macrocycle structure-activity relationship analysis, enhancing the efficiency of macrocycle-based drug discovery effort.
With advancements in drug delivery strategies, there is a surge in demand for peptide-drug conjugation techniques, creating opportunities in the market. This method allows for precisely targeting specific cells or tissues, enhancing drug efficacy while minimizing side effects. Furthermore, accurate prediction of peptide-target binding affinity is crucial for drug discovery platforms. By combining experimental data and computer models, companies can speed up the medication development process and lower costs and time-to-market.
However, technical limitations in binding affinity prediction and safety and toxicity concerns may impede market growth over the forecast period.
The peptide synthesis segment is expected to hold the largest share of the market over the forecast period. The pharmaceutical sector has used sophisticated peptide synthesis techniques extensively for many years. Researchers and medication developers prefer this proven technique as it provides a scalable and dependable approach to manufacturing peptides.
The medicinal chemistry segment is expected to be the fastest-growing segment in the market from 2024 to 2029. The potency, selectivity, pharmacokinetics, and safety characteristics of therapeutic candidates are all optimized via medicinal chemistry. Through the application of medicinal chemistry methodologies, researchers can methodically alter the structures of peptides and macrocycles to augment their therapeutic efficacy and target certain disease targets.
The oncology segment is expected to hold the largest share of the market over the forecast period. Targeted treatment benefits from the specific inhibition of cancer-associated targets made possible by peptide-based medications and macrocycles, which also reduce the risk of off-target effects on healthy tissues. This focused strategy aligns with the oncology precision medicine paradigm, which customizes treatments for each patient according to their molecular and genetic profiles.
The neurological conditions segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Complex pathophysiological pathways, including misfolded proteins, abnormal neuronal signaling, inflammation, and neurodegeneration, are characteristics of neurological disorders. Since they specifically target the biochemical pathways and protein targets linked to neurological disorders, peptides, and macrocycles have special benefits in modifying these processes.
North America is expected to be the largest region in the global market. The regional market is growing due to its sophisticated research infrastructure, which includes cutting-edge labs, universities, and biotechnology centers. The region attracts talent and investment due to its top research facilities and technological platforms fostering innovation in peptide and macrocycle drug development.
Asia Pacific is anticipated to witness rapid growth during the forecast period. The pharmaceutical sector in the Asia Pacific area is developing quickly due to several factors, including rising healthcare costs, a growing need for novel treatments, and easier access to healthcare services. Investment opportunities in peptide and macrocycle drug discovery platforms are created by this growth, which aims to solve unmet medical needs and promote the development of innovative treatments.
Pfizer, Novartis, AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi, Bristol-Myers Squibb, Genentech, and Boehringer Ingelheim, among others, are some of the key players in the global peptides and macrocycle drug discovery platforms market.
Please note: This is not an exhaustive list of companies profiled in the report.
In May 2024, Novartis and PeptiDream extended their partnership on peptide discovery with a new deal valued at over USD 2.8 billion. Under the terms of the multi-program agreement, PeptiDream will find and optimize macrocyclic peptides against Novartis-selected targets by utilizing its unique Peptide Discovery Platform System technology.
In January 2023, Merck & Co. signed the USD 220 million macrocyclic peptide deal with Unnatural Products, a California-based biotech company that tackles the challenges of medicinal chemistry in the macrocycle domain by combining its expertise in chemistry and artificial intelligence.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PEPTIDES AND MACROCYCLE DRUG DISCOVERY PLATFORMS MARKET, BY Type of Platform
4.1 Introduction
4.2 Peptides and Macrocycle Drug Discovery Platforms Market: Type of Platform Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Peptide Synthesis
4.4.1 Peptide Synthesis Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Screening Assays
4.5.1 Screening Assays Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Structural Biology
4.6.1 Structural Biology Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Computational Modeling
4.7.1 Computational Modeling Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Medicinal Chemistry
4.8.1 Medicinal Chemistry Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL PEPTIDES AND MACROCYCLE DRUG DISCOVERY PLATFORMS MARKET, BY APPLICATION
5.1 Introduction
5.2 Peptides and Macrocycle Drug Discovery Platforms Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Oncology
5.4.1 Oncology Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Infectious Diseases
5.5.1 Infectious Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Autoimmune Disorders
5.6.1 Autoimmune Disorders Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Metabolic Diseases
5.7.1 Metabolic Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
5.8 Neurological Conditions
5.8.1 Neurological Conditions Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL PEPTIDES AND MACROCYCLE DRUG DISCOVERY PLATFORMS MARKET, BY REGION
6.1 Introduction
6.2 North America Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Type of Platform
6.2.2 By Application
6.2.3 By Country
6.2.3.1 U.S. Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Type of Platform
6.2.3.1.2 By Application
6.2.3.2 Canada Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Type of Platform
6.2.3.2.2 By Application
6.2.3.3 Mexico Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Type of Platform
6.2.3.3.2 By Application
6.3 Europe Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Type of Platform
6.3.2 By Application
6.3.3 By Country
6.3.3.1 Germany Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Type of Platform
6.3.3.1.2 By Application
6.3.3.2 U.K. Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Type of Platform
6.3.3.2.2 By Application
6.3.3.3 France Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Type of Platform
6.3.3.3.2 By Application
6.3.3.4 Italy Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Type of Platform
6.3.3.4.2 By Application
6.3.3.5 Spain Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Type of Platform
6.3.3.5.2 By Application
6.3.3.6 Netherlands Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type of Platform
6.3.3.6.2 By Application
6.3.3.7 Rest of Europe Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type of Platform
6.3.3.6.2 By Application
6.4 Asia Pacific Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Type of Platform
6.4.2 By Application
6.4.3 By Country
6.4.3.1 China Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Type of Platform
6.4.3.1.2 By Application
6.4.3.2 Japan Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Type of Platform
6.4.3.2.2 By Application
6.4.3.3 India Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Type of Platform
6.4.3.3.2 By Application
6.4.3.4 South Korea Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Type of Platform
6.4.3.4.2 By Application
6.4.3.5 Singapore Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Type of Platform
6.4.3.5.2 By Application
6.4.3.6 Malaysia Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type of Platform
6.4.3.6.2 By Application
6.4.3.7 Thailand Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type of Platform
6.4.3.6.2 By Application
6.4.3.8 Indonesia Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Type of Platform
6.4.3.7.2 By Application
6.4.3.9 Vietnam Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Type of Platform
6.4.3.8.2 By Application
6.4.3.10 Taiwan Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Type of Platform
6.4.3.10.2 By Application
6.4.3.11 Rest of Asia Pacific Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Type of Platform
6.4.3.11.2 By Application
6.5 Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Type of Platform
6.5.2 By Application
6.5.3 By Country
6.5.3.1 Saudi Arabia Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Type of Platform
6.5.3.1.2 By Application
6.5.3.2 U.A.E. Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Type of Platform
6.5.3.2.2 By Application
6.5.3.3 Israel Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Type of Platform
6.5.3.3.2 By Application
6.5.3.4 South Africa Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Type of Platform
6.5.3.4.2 By Application
6.5.3.5 Rest of Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Type of Platform
6.5.3.5.2 By Application
6.6 Central and South America Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Type of Platform
6.6.2 By Application
6.6.3 By Country
6.6.3.1 Brazil Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Type of Platform
6.6.3.1.2 By Application
6.6.3.2 Argentina Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Type of Platform
6.6.3.2.2 By Application
6.6.3.3 Chile Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type of Platform
6.6.3.3.2 By Application
6.6.3.3 Rest of Central and South America Peptides and Macrocycle Drug Discovery Platforms Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type of Platform
6.6.3.3.2 By Application
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Pfizer
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Novartis
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 AstraZeneca
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Eli Lilly
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Merck
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 NOVO NORDISK
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Sanofi
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Bristol-Myers Squibb
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Genentech
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Boehringer Ingelheim
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
2 Peptide Synthesis Market, By Region, 2021-2029 (USD Mllion)
3 Screening Assays Market, By Region, 2021-2029 (USD Mllion)
4 Structural Biology Market, By Region, 2021-2029 (USD Mllion)
5 Computational Modeling Market, By Region, 2021-2029 (USD Mllion)
6 Medicinal Chemistry Market, By Region, 2021-2029 (USD Mllion)
7 Global Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
8 Oncology Market, By Region, 2021-2029 (USD Mllion)
9 Infectious Diseases Market, By Region, 2021-2029 (USD Mllion)
10 Autoimmune Disorders Market, By Region, 2021-2029 (USD Mllion)
11 Metabolic Diseases Market, By Region, 2021-2029 (USD Mllion)
12 Neurological Conditions Market, By Region, 2021-2029 (USD Mllion)
13 Regional Analysis, 2021-2029 (USD Mllion)
14 North America Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
15 North America Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
16 North America Peptides and Macrocycle Drug Discovery Platforms Market, By COUNTRY, 2021-2029 (USD Mllion)
17 U.S. Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
18 U.S. Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
19 Canada Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
20 Canada Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
21 Mexico Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
22 Mexico Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
23 Europe Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
24 Europe Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
25 EUROPE Peptides and Macrocycle Drug Discovery Platforms Market, By COUNTRY, 2021-2029 (USD Mllion)
26 Germany Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
27 Germany Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
28 U.K. Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
29 U.K. Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
30 France Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
31 France Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
32 Italy Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
33 Italy Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
34 Spain Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
35 Spain Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
36 Netherlands Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
37 Netherlands Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
38 Rest Of Europe Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
39 Rest Of Europe Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
40 Asia Pacific Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
41 Asia Pacific Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
42 ASIA PACIFIC Peptides and Macrocycle Drug Discovery Platforms Market, By COUNTRY, 2021-2029 (USD Mllion)
43 China Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
44 China Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
45 Japan Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
46 Japan Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
47 India Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
48 India Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
49 South Korea Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
50 South Korea Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
51 Singapore Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
52 Singapore Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
53 Thailand Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
54 Thailand Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
55 Malaysia Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
56 Malaysia Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
57 Indonesia Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
58 Indonesia Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
59 Vietnam Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
60 Vietnam Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
61 Taiwan Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
62 Taiwan Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
63 Rest of APAC Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
64 Rest of APAC Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
65 Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
66 Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
67 Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market, By COUNTRY, 2021-2029 (USD Mllion)
68 Saudi Arabia Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
69 Saudi Arabia Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
70 UAE Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
71 UAE Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
72 Israel Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
73 Israel Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
74 South Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
75 South Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
76 Rest Of Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
77 Rest Of Middle East and Africa Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
78 Central and South America Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
79 Central and South America Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
80 CENTRAL AND SOUTH AMERICA Peptides and Macrocycle Drug Discovery Platforms Market, By COUNTRY, 2021-2029 (USD Mllion)
81 Brazil Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
82 Brazil Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
83 Chile Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
84 Chile Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
85 Argentina Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
86 Argentina Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
87 Rest Of Central and South America Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform, 2021-2029 (USD Mllion)
88 Rest Of Central and South America Peptides and Macrocycle Drug Discovery Platforms Market, By Application, 2021-2029 (USD Mllion)
89 Pfizer: Products & Services Offering
90 Novartis: Products & Services Offering
91 AstraZeneca: Products & Services Offering
92 Eli Lilly: Products & Services Offering
93 Merck: Products & Services Offering
94 NOVO NORDISK: Products & Services Offering
95 Sanofi: Products & Services Offering
96 Bristol-Myers Squibb: Products & Services Offering
97 Genentech, Inc: Products & Services Offering
98 Boehringer Ingelheim: Products & Services Offering
99 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Peptides and Macrocycle Drug Discovery Platforms Market Overview
2 Global Peptides and Macrocycle Drug Discovery Platforms Market Value From 2021-2029 (USD Mllion)
3 Global Peptides and Macrocycle Drug Discovery Platforms Market Share, By Type of Platform (2023)
4 Global Peptides and Macrocycle Drug Discovery Platforms Market Share, By Application (2023)
5 Global Peptides and Macrocycle Drug Discovery Platforms Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Peptides and Macrocycle Drug Discovery Platforms Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Peptides and Macrocycle Drug Discovery Platforms Market
10 Impact Of Challenges On The Global Peptides and Macrocycle Drug Discovery Platforms Market
11 Porter’s Five Forces Analysis
12 Global Peptides and Macrocycle Drug Discovery Platforms Market: By Type of Platform Scope Key Takeaways
13 Global Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform Segment: Revenue Growth Analysis
14 Peptide Synthesis Market, By Region, 2021-2029 (USD Mllion)
15 Screening Assays Market, By Region, 2021-2029 (USD Mllion)
16 Structural Biology Market, By Region, 2021-2029 (USD Mllion)
17 Computational Modeling Market, By Region, 2021-2029 (USD Mllion)
18 Medicinal Chemistry Market, By Region, 2021-2029 (USD Mllion)
19 Global Peptides and Macrocycle Drug Discovery Platforms Market: By Application Scope Key Takeaways
20 Global Peptides and Macrocycle Drug Discovery Platforms Market, By Application Segment: Revenue Growth Analysis
21 Oncology Market, By Region, 2021-2029 (USD Mllion)
22 Infectious Diseases Market, By Region, 2021-2029 (USD Mllion)
23 Autoimmune Disorders Market, By Region, 2021-2029 (USD Mllion)
24 Metabolic Diseases Market, By Region, 2021-2029 (USD Mllion)
25 Neurological Conditions Market, By Region, 2021-2029 (USD Mllion)
26 Global Peptides and Macrocycle Drug Discovery Platforms Market: Regional Analysis
27 North America Peptides and Macrocycle Drug Discovery Platforms Market Overview
28 North America Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform
29 North America Peptides and Macrocycle Drug Discovery Platforms Market, By Application
30 North America Peptides and Macrocycle Drug Discovery Platforms Market, By Country
31 U.S. Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform
32 U.S. Peptides and Macrocycle Drug Discovery Platforms Market, By Application
33 Canada Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform
34 Canada Peptides and Macrocycle Drug Discovery Platforms Market, By Application
35 Mexico Peptides and Macrocycle Drug Discovery Platforms Market, By Type of Platform
36 Mexico Peptides and Macrocycle Drug Discovery Platforms Market, By Application
37 Four Quadrant Positioning Matrix
38 Company Market Share Analysis
39 Pfizer: Company Snapshot
40 Pfizer: SWOT Analysis
41 Pfizer: Geographic Presence
42 Novartis: Company Snapshot
43 Novartis: SWOT Analysis
44 Novartis: Geographic Presence
45 AstraZeneca: Company Snapshot
46 AstraZeneca: SWOT Analysis
47 AstraZeneca: Geographic Presence
48 Eli Lilly: Company Snapshot
49 Eli Lilly: Swot Analysis
50 Eli Lilly: Geographic Presence
51 Merck: Company Snapshot
52 Merck: SWOT Analysis
53 Merck: Geographic Presence
54 NOVO NORDISK: Company Snapshot
55 NOVO NORDISK: SWOT Analysis
56 NOVO NORDISK: Geographic Presence
57 Sanofi : Company Snapshot
58 Sanofi : SWOT Analysis
59 Sanofi : Geographic Presence
60 Bristol-Myers Squibb: Company Snapshot
61 Bristol-Myers Squibb: SWOT Analysis
62 Bristol-Myers Squibb: Geographic Presence
63 Genentech, Inc.: Company Snapshot
64 Genentech, Inc.: SWOT Analysis
65 Genentech, Inc.: Geographic Presence
66 Boehringer Ingelheim: Company Snapshot
67 Boehringer Ingelheim: SWOT Analysis
68 Boehringer Ingelheim: Geographic Presence
69 Other Companies: Company Snapshot
70 Other Companies: SWOT Analysis
71 Other Companies: Geographic Presence
The Global Peptides and Macrocycle Drug Discovery Platforms Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Peptides and Macrocycle Drug Discovery Platforms Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
